
SOLV — Solventum Corp.
NYSE · Healthcare · Medical Instruments & Supplies
$90.95
-$0.11 (-0.12%)
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE. It is led by Bryan C. Hanson, based in 1750 Yankee Doodle Road, Eagan, MN, United States, 55121, with about 20,584 employees. Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Latest reported SOLV revenue for 2025-09-30 was $2.10B. Net income was $1.27B. Revenue was down 3.0% from 2025-06-30 to 2025-09-30. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Use this SOLV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SOLV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SOLV SEC filings page. Lician reads the product cache first so this HTML stays unique to Solventum Corp. even when a live quote feed is slow.
About Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
SOLV Key Statistics
Market Cap
$12.91B
Volume
1.02M
Previous Close
$91.25
Day Range
$90.35 – $92.05
P/E Ratio
9.13
P/B Ratio
2.60
EPS
$2.76
Revenue
$8.25B
Net Income
$479.00M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+0.7%
Profit Margin
5.8%
Employees
20,584
SOLV Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $8.25B | $8.20B | $8.13B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | $479.00M | $1.35B | $1.34B |
| EPS (Diluted) | $2.76 | $7.79 | $7.78 |
Total Assets
$14.46B
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$762.00M
Operating Cash Flow
$1.19B
Free Cash Flow
$0.00
Solventum Corp. Company Information
- CEO & Director
- Bryan C. Hanson
- Headquarters
- 1750 Yankee Doodle Road, Eagan, MN, United States, 55121
- Website
- www.solventum.com
- Phone
- (651) 733-1110
- IPO / Founded
- 2024-03-26
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies